Skip to main content
. 2020 Dec 14;288(6):682–688. doi: 10.1111/joim.13198

Figure 1.

Figure 1

(a) Linear regression analysis of the total number of BCG‐NVP years and relative age‐standardized mortality rates in European countries. Countries that never had BCG‐NVPs for young children were assigned the ‘mock year’ 1950, which is the approximated average year the other countries started. (b) Linear regression analysis of year of discontinuation of neonatal BCG vaccine in the NVP and relative age‐standardized mortality rates in European countries. Spain, Portugal and Switzerland were excluded from this analysis due to late start of BCG‐NVP (1965, 1965 and 1960, respectively).